All studies
AuthorisedHuman Pharmacology (Phase I)- OtherInterventional

EVALUATION OF PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF A NOVEL NICOTINE THERAPY IN HEALTHY SMOKERS

Many people smoke and find it hard to quit because nicotine is very addictive. Nicotine replacement products, like patches or gums, can help people manage cravings. This Phase 1 clinical trial is testing a new kind of nicotine treatment in healthy adults who currently smoke. The main aim is to understand how the body handles this new treatment. Doctors will measure how quickly nicotine enters the bloodstream, how long it stays there, and how the body responds to it. They will also look closely at safety and side effects, such as mild nausea or dizziness. Taking part usually involves health checks, taking the study product, and having blood samples collected over set periods. This study is an important first step in finding out whether this new product could be developed into a helpful stop-smoking option in the future.

At a glance

Status
Authorised
Phase
Human Pharmacology (Phase I)- Other
Sponsor
Flik Therapeutics Inc.
Enrolment target
18
Start
01 Oct 2026

What is this study about?

Giving up smoking is one of the best things a person can do for their health, but it can be very difficult. Cigarettes contain nicotine, a chemical that causes strong cravings and dependence. Treatments that replace nicotine without the harmful chemicals found in tobacco smoke can help people cut down or stop smoking altogether.

This study is testing a new type of nicotine therapy. Because it is in the early stages of research, known as a Phase 1 trial, it is being tested in a small group of healthy adult smokers. Researchers want to see how the treatment works in the human body. They will study how fast the nicotine is absorbed, how it travels through the blood, and how the body clears it away.

Doctors will also carefully monitor volunteers to make sure the product is well tolerated. They will check for any unexpected reactions or uncomfortable symptoms. If the product proves to be safe and behaves well in the body, it may move on to larger studies to test how effectively it helps people stop smoking.

Key takeaways

  • Tests a new nicotine therapy in healthy adult smokers.
  • Early-stage trial focused on safety and how the body absorbs nicotine.
  • Involves health checks, taking the study product, and blood tests.
  • Does not promise to help you stop smoking immediately.
  • Participation is voluntary, and you can stop taking part at any time.

Who may be eligible?

This study is looking for healthy adults aged 18 and over who regularly smoke cigarettes. Because this is a very early test of the treatment, researchers need people whose bodies are already used to nicotine.

You will need to be in generally good health. People with serious medical conditions, such as heart disease, uncontrolled high blood pressure, or major lung problems, are usually not able to take part. This is to ensure participant safety and keep the test results clear.

You will also likely be excluded if you are pregnant, planning to become pregnant, or breastfeeding. The study team will carry out standard health checks, such as blood pressure and heart tests, before confirming if you can join.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you aged 18 or older?
  2. Do you currently smoke cigarettes on a regular basis?
  3. Are you in generally good physical health?
  4. Are you free from serious heart, lung, or kidney conditions?
  5. Are you neither pregnant nor currently breastfeeding?
Answer every question to see your result.

What does participation involve?

If you take part, you will be invited to a research clinic for an initial screening visit. The team will explain the study, answer your questions, and carry out basic health checks like blood tests, a heart tracing (ECG), and blood pressure measurements.

During the study, you will be given the new nicotine product to use under medical supervision. The research team will take regular blood samples over several hours to measure how much nicotine enters your bloodstream and how fast it clears. You will also be asked how you feel and whether you notice any side effects. Total participation may involve one or more clinic visits or a short stay at the research unit, followed by a brief check-up to ensure you are well.

Potential risks and benefits

Taking part in an early trial like this will not directly treat your nicotine dependence or cure any illness, though you will receive free general health checks. The findings may help scientists design better tools to help people quit smoking in the future. As with any nicotine product, there is a risk of side effects. Common reactions might include a fast heart rate, headache, mild nausea, dizziness, or irritation where the product is applied. You may also get slight bruising from blood tests. Your safety is closely watched throughout, and you are free to leave the trial at any time without giving a reason.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Poland

Common questions

What does a Phase 1 trial mean?

A Phase 1 trial is one of the earliest stages of testing in humans. It focuses mainly on safety, side effects, and how the body handles the study product.

Will taking part help me quit smoking right away?

No, this trial is not designed as a quit-smoking programme. Its purpose is only to test how the body absorbs and tolerates this new form of nicotine.

Do I have to pay to take part?

No. The study treatment and all medical checks are provided free of charge, and participants are often compensated for their time and travel.

Can I leave the study if I change my mind?

Yes. You can leave the study at any point without needing an explanation, and it will not affect your regular NHS medical care.

What happens to my personal information?

Your medical details are kept strictly confidential and are handled according to strict UK data protection and privacy laws.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.